30
July

07:00 PM PT

From IND to Market: Building Scalable Strategies
Across the Biotech Lifecycle

STK Steakhouse, San Francisco, California

What to expect

Timely information, interactive format

Navigating the complex path from Investigational New Drug (IND) application to commercial launch requires strategic foresight, operational agility, and cross-functional alignment. In this presentation, WEP Clinical outlines a scalable, patient-centric approach to supporting biotech companies across all stages of the product lifecycle. From early access programs and regulatory strategy to global distribution and commercialization, we demonstrate how tailored solutions can accelerate timelines, optimize resources, and de-risk market entry. Drawing on real-world experience and proven success across diverse therapeutic areas, we share insights into building sustainable frameworks that adapt as products progress from first patient dosing to full market commercial availability.

Our Agenda

Meet Our Facilitators

Dr. Atalah Haun

Vice President, Global Medical Affairs WEP

Brian Tanner

Head of Global Clinical Strategy WEP

More about WEP

More information

At WEP, we are With Every Patient, as we believe every patient should have access to treatment. With this as our guiding principle, we operate as a Complete CRO, with a proven track record of excellence in designing, managing, and executing Clinical Trials, Expanded Access Programs (EAPs), and Commercialization Solutions across the globe. Through our strong customer service and proactive project management, we are committed to scientific integrity, regulatory compliance, and patient-centric research, helping Sponsors advance their life-changing therapies while providing greater access opportunities to patients. –www.wepclinical.com

Register Now

As the event is hosted in person, attendance is limited. We want to make sure your experience with us is relevant. Therefore, we will confirm each registered guest individually. Please check your inbox for the confirmation email.

*To be eligible to attend, you must be from a drug development company that has a current and public drug pipeline.

*First name

*Last name

*Company name

*Job Title

*First line of address

*City

*Postcode/Zipcode

*Country

*Work Email

*Direct Line

*Mobile/Cell

*What are your 3 main strategic challenges?

Do you have dietary requirements?

YesNo

If yes please indicate

***We Highly Recommend to Use Google Chrome, Safari or Firefox Browser.

I hereby consent Proventa International to collect and share my provided contact details to other delegates and sponsors attending the same event I am attending.

I agree to Proventa International using this information to contact me about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy.

Further Information

Interested in attending this strategy dinner or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Europe

R&D

R&D Dinners & Spotlights

MaxisIT Dinner – 19th May

From IND to Market: Building Scalable Strategies Across the Biotech Lifecycle

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >STK Steakhouse, San Francisco, California

Timely information, interactive format

Our Agenda

Cocktails and Networking

Roundtable Discussion

Dinner

Coffee, Dessert, Cognac, Closing Remarks

Meet Our Facilitators

Dr. Atalah Haun

Brian Tanner

More about WEP

Register Now

You had been successfully registered.

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

From IND to Market: Building Scalable Strategies
Across the Biotech Lifecycle

STK Steakhouse, San Francisco, California